The IL-2/IL-15 Receptor Systems: Targets for Immunotherapy

This publication has 50 references indexed in Scilit:

• Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial
  Proceedings of the National Academy of Sciences, 1999
• Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.
  1998
• Soluble IL-15 Receptor α-Chain Administration Prevents Murine Collagen-Induced Arthritis: A Role for IL-15 in Development of Antigen-Induced Immunopathology
  The Journal of Immunology, 1998
• The Transcription Factor Interferon Regulatory Factor 1 (IRF-1) Is Important during the Maturation of Natural Killer 1.1+ T Cell Receptor–α/β+ (NK1+ T) Cells, Natural Killer Cells, and Intestinal Intraepithelial T Cells
  The Journal of Experimental Medicine, 1998
• Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
  Nature, 1998
• Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.
  1995
• The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
  Proceedings of the National Academy of Sciences, 1994
• A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
  Proceedings of the National Academy of Sciences, 1994
• Development and proliferation of lymphocytes in mice deficient for both interleukins‐2 and ‐4
  European Journal of Immunology, 1994
• Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-7 Receptor
  Science, 1993